🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Risk Factors for AKI in Patients Undergoing VATS for Pulmonary Resection

Recruitingn/aAges 18 Years - 65 YearsAllAtatürk Chest Diseases and Chest Surgery Training…
NCT06341933 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to investigate the potential factors contributing to the development of Acute Kidney Injury (AKI) in patients undergoing pulmonary resection with Video Assisted Thoracoscopic Surgery (VATS) for lung malignancy. The study will focus on demographic data, laboratory parameters, perioperative fluid management, and haemodynamics. The research will be conducted at SBÜ Ankara Atatürk Sanatorium Training and Research Hospital. The study will involve patients who have given informed consent and will undergo VATS with standard anaesthesia monitoring. Anaesthesia management will follow our routine protocol in our clinic. Patients will be divided into two groups based on whether they have a more than 25% decrease in estimated glomerular filtration rate (t-GFH) and/or a 1.5-fold increase in serum creatinine and/or a 6-hour urine volume of less than 0.5 ml/kg/h. The patients will be

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Over 18 years of age, under 65 years of age, * American Society of Anesthesiologists (ASA) physical status 1-3, * Data of patients who will undergo wedge resection, segmentectomy or lobectomy with elective VATS due to lung malignancy will be examined prospectively. Exclusion Criteria: * Patients with a body mass index (BMI) less than 18.5kg/m2 or greater than 35 kg/m2, * Those with impaired renal function (the upper limit of the creatinine reference range is more than 50%; 1.3 mg/dL for men and 1.1 mg/dL for women), * A radiological examination was performed using radiocontrast material in the preoperative period, * Clinically and radiologically diagnosed with congestive heart failure and treatment has been started, * Having a history of pulmonary edema, * Those who have used steroids and non-steroidal anti-inflammatory drugs for a long time (exceeding 30 days), * Intubated to intensive care unit, * In need of massive peroperative blood transfusion, * Patients with deficiencies in the parameters examined will be excluded from the study.
💊

What it tests

  • Duration of Surgery
  • Volume of Fluid in Surgery
  • Blood Loss
📍

Where

1 site
Ankara Atatürk Sanatorium Training and Research Hospital
Ankara, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy